Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer

Go back to Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
(NASDAQ: AQST) Delayed: 5.24 --0 (-0%)
Previous Close $5.24    52 Week High
Open $5.24    52 Week Low
Day High $5.24    P/E N/A 
Day Low $5.24    EPS
Volume 12